Plantago Primula NDC 48951-8034

NDC codes

FDA NDC Directory

Product NDC (as listed)48951-8034Labeler and product segments. Claims need a package NDC.

Product NDC at billing width48951-8034Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
48951-8034-1	48951803401	10 AMPULE in 1 BOX (48951-8034-1) / 1 mL in 1 AMPULEMarketed from Sep 1, 2009

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Plantago Primula
Generic name (nonproprietary): plantago primula
Active ingredients: Plantago major leaf — 2 [hp_X]/mLPrimula veris flower — 2 [hp_X]/mLHyoscyamus niger leaf — 3 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Uriel Pharmacy Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Sep 1, 2009
Listing expires: Dec 31, 2026
Identifiers: Product ID 48951-8034_2c522c57-994b-4e02-e063-6394a90a1f12SPL ID 2c522c57-994b-4e02-e063-6394a90a1f12SPL set ID 25545753-2d00-47fe-b318-b7e4a47c3d0dUNII 7DC28K241X, W5BET37294, 32IT7G8BAW

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N448951803401 followed by a unit qualifier and the quantity

Package 48951-8034-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2025.

Indications (excerpt from the label)

Directions: FOR ORAL USE.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)